The Effect of Repeated Simulation in Developing Social Justice Advocacy Attitudes and Skills on Nursing Student
1 other identifier
interventional
48
1 country
1
Brief Summary
It is a randomized controlled experimental and single-blind study with a pretest-posttest control group design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 30, 2023
CompletedFirst Submitted
Initial submission to the registry
July 21, 2023
CompletedFirst Posted
Study publicly available on registry
July 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedJanuary 29, 2025
January 1, 2025
5 months
July 21, 2023
January 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Repeated simulation
Repeated simulation is effective in developing nursing students' social justice advocacy attitudes and skills. Students' social justice advocacy attitudes will be measured with the "Social Justice Advocacy Scale". The scale is a 7-point Likert-type scale. 1 means "Absolutely Not True" and 7 means "Absolutely True". The minimum score is 41 and the maximum score is 287 from the scale; it is stated that as the scores obtained from the scale increase, social justice advocacy skills also increase. Students' advocacy skills will be measured with the "Social Justice Advocacy Skills Assessment Guide". The scoring in the guide was as follows: "Not Done = 0, insufficient performance = 1 and sufficient performance = 2.". The minimum score received from the guide is 0 and the maximum score is 48; as the total score received from the guide increases, the students' advocacy application skill levels are considered to be higher.
four weeks
Study Arms (2)
experimental group
EXPERIMENTALThey will perform repetitive simulation (standard patient simulation according to scenarios) with the students in the experimental group.
control group
OTHERA single simulation will be applied to the control group (standard patient simulation according to scenarios).
Interventions
Experimental Group-Repetitive Simulation * First simulation application; It will be done in groups of four with a total of 5 groups (n=20). In each scenario, one student in the group will participate in the role of nurse and three other students will participate as audience. Four students in each group will take part in a standard patient simulation consisting of four different scenarios. * Second simulation application; It will be carried out with the students in the experimental group about 3-4 weeks after the first simulation. Each student will use one new scenario alone in the second simulation.
Eligibility Criteria
You may qualify if:
- Volunteering to participate in the research Being a 4th year undergraduate nursing student Having completed the theoretical education for vocational courses
You may not qualify if:
- Being a foreign national (due to Turkish speaking/understanding problem)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (1)
Ege University
Izmir, 35100, Turkey (Türkiye)
Study Officials
- STUDY CHAIR
Süheyla Özsoy, Prof
suheyla.ozsoy@ege.edu.tr
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- research assistant
Study Record Dates
First Submitted
July 21, 2023
First Posted
July 28, 2023
Study Start
March 30, 2023
Primary Completion
August 30, 2023
Study Completion
September 30, 2023
Last Updated
January 29, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share